Differential IL‐10 production by DCs determines the distinct adjuvant effects of LPS and PTX in EAE induction. Issue 5 (7th March 2014)

• Record Type: Journal Article
• Authors: Zhou, Haiyan; Wang, Yanming; Lian, Qiaoshi; Yang, Bo; Ma, Yonglei; Wu, Xiaodong; Sun, Shuhui; Liu, Yongjun; Sun, Bing
• Is Part Of: European journal of immunology. Volume 44:Issue 5(2014:May)
• Page Start: 1352
• Page End: 1362
• Publication Date: 2014-03-07
• Subjects: Immunology -- Periodicals; 616.079
• DOI: 10.1002/eji.201343744
• Languages: English
• ISSNs: 0014-2980

Abstract

<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <p>Pertussis toxin (PTX) is used as an adjuvant to induce EAE in mice as a model of MS. Although LPS and PTX are similar in their ability to mature dendritic cells (DCs) and in their adjuvant properties, here we demonstrate that LPS does not induce EAE development. We also demonstrate that DCs treated with PTX (PTX‐DCs) are able to induce EAE, whereas DCs treated with LPS (LPS‐DCs) fail to induce EAE. We determine that a key difference between LPS‐DCs and PTX‐DCs is that LPS‐DCs produce larger amounts of IL‐10. IL‐10^−/−‐DCs treated with LPS promote stronger IFN‐γ and IL‐17 production and T‐cell proliferation than WT DCs treated with LPS in a coculture system. Finally, we demonstrate that EAE can be successfully induced when IL‐10^−/−‐DCs treated with LPS are used as an adjuvant, whereas the use of PTX‐DCs overexpressing IL‐10 as an adjuvant markedly controls EAE development. These results indicate that the inability of LPS to induce EAE is based on the induction of high levels of IL‐10 in the targeted DCs, providing insight into the mechanisms responsible for the induction of EAE.</p> </abstract>